Research graph
References from Proteomic Profiling of Nodal T‐Follicular Helper Cell Lymphoma Reveals Distinct Biological Signatures and Improves Prognostic Stratification Beyond the IPI. Local targets link to admitted publications; unresolved targets remain external evidence.
Peripheral T‐Cell Lymphoma: Are All Patients High Risk?
10.1182/blood.2023020912 · 2024 · External reference
Molecular Subtypes of Diffuse Large B Cell Lymphoma Are Associated With Distinct Pathogenic Mechanisms and Outcomes
10.1038/s41591-018-0016-8 · 2018 · External reference
Five‐Year Follow‐Up of ZUMA‐1 Supports the Curative Potential of Axicabtagene Ciloleucel in Refractory Large B‐Cell Lymphoma
2023 · External reference
The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
10.1038/s41375-022-01620-2 · 2022 · External reference
A Targeted Mutational Landscape of Angioimmunoblastic T‐Cell Lymphoma
10.1182/blood-2013-10-531509 · 2014 · External reference
Integrative Analysis of a Phase 2 Trial Combining Lenalidomide With CHOP in Angioimmunoblastic T‐Cell Lymphoma
10.1182/bloodadvances.2020003081 · 2021 · External reference
Multicenter Phase 2 Study of Oral Azacitidine (CC‐486) Plus CHOP as Initial Treatment for PTCL
2023 · External reference
Oral Azacitidine Compared With Standard Therapy in Patients With Relapsed or Refractory Follicular Helper T‐Cell Lymphoma (ORACLE): An Open‐Label Randomised, Phase 3 Study
10.1016/s2352-3026(24)00102-9 · 2024 · External reference
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma
10.1002/ajh.27736 · 2025 · External reference
Outcomes and Prognostic Factors in Angioimmunoblastic T‐Cell Lymphoma: Final Report From the International T‐Cell Project
10.1182/blood.2020010387 · 2021 · External reference
Comprehensive Comparison of International Prognostic Indexes for Follicular Helper T‐Cell Lymphoma
10.1007/s00277-022-04805-y · 2022 · External reference
On the Dependency of Cellular Protein Levels on mRNA Abundance
10.1016/j.cell.2016.03.014 · 2016 · External reference
A Survey of Best Practices for RNA‐Seq Data Analysis
10.1186/s13059-016-0881-8 · 2016 · External reference
Why Proteomics Is Not the New Genomics and the Future of Mass Spectrometry in Cell Biology
10.1083/jcb.201612010 · 2017 · External reference
Proteomic Analysis Identifies Galectin‐1 as a Predictive Biomarker for Relapsed/Refractory Disease in Classical Hodgkin Lymphoma
10.1182/blood-2010-12-327346 · 2011 · External reference
Histologically Transformed Follicular Lymphoma Exhibits Protein Profiles Different From Both Non‐Transformed Follicular and de Novo Diffuse Large B‐Cell Lymphoma
10.1038/bcj.2015.18 · 2015 · External reference
Proteomic Profiling Identifies Outcome‐Predictive Markers in Patients With Peripheral T‐Cell Lymphoma, Not Otherwise Specified
10.1182/bloodadvances.2018019893 · 2018 · External reference
Proteomics Identifies Circulating TIMP‐1 as a Prognostic Biomarker for Diffuse Large B‐Cell Lymphoma
10.1016/j.mcpro.2023.100625 · 2023 · External reference
A Novel LC System Embeds Analytes in Pre‐Formed Gradients for Rapid, Ultra‐Robust Proteomics *
10.1074/mcp.tir118.000853 · 2018 · External reference
DIA‐NN: Neural Networks and Interference Correction Enable Deep Proteome Coverage in High Throughput
10.1038/s41592-019-0638-x · 2020 · External reference
dia‐PASEF Data Analysis Using FragPipe and DIA‐NN for Deep Proteomics of Low Sample Amounts
10.1038/s41467-022-31492-0 · 2022 · External reference
OpenProt 2.0 Builds a Path to the Functional Characterization of Alternative Proteins
10.1093/nar/gkad1050 · 2024 · External reference
Reactome Diagram Viewer: Data Structures and Strategies to Boost Performance
2018 · External reference
10.1093/bioinformatics/btaf644
10.1093/bioinformatics/btaf644 · External reference
Real‐Time Glioblastoma Tumor Microenvironment Assessment by SpiderMass for Improved Patient Management
10.1016/j.xcrm.2024.101482 · 2024 · External reference
Protocol to Analyze 1D and 2D Mass Spectrometry Data From Glioblastoma Tissues for Cancer Diagnosis and Immune Cell Identification
10.1016/j.xpro.2024.103285 · 2024 · External reference
Predicting Protein Pathways Associated to Tumor Heterogeneity by Correlating Spatial Lipidomics and Proteomics: The Dry Proteomic Concept
10.1016/j.mcpro.2024.100891 · 2025 · External reference
10.1007/978-3-319-19425-7_13
10.1007/978-3-319-19425-7_13 · 2015 · External reference
Unresolved reference
2017 · External reference
Discrete Genetic Subtypes and Tumor Microenvironment Signatures Correlate With Peripheral T‐Cell Lymphoma Outcomes
10.1038/s41375-025-02563-0 · 2025 · External reference
The Extracellular Matrix: A Dynamic Niche in Cancer Progression
10.1083/jcb.201102147 · 2012 · External reference
Platelets and Cancer Angiogenesis Nexus
10.1007/s10555-017-9673-1 · 2017 · External reference
Cancer genome landscapes
10.1126/science.1235122 · 2013 · External reference
TP53 and CDKN2A Alterations Define a Poor Prognostic Subgroup in Patients With Nodal T Follicular Helper Cell Lymphoma
10.1038/s41375-025-02631-5 · 2025 · External reference
Genetic Drivers of Oncogenic Pathways in Molecular Subgroups of Peripheral T‐Cell Lymphoma
10.1182/blood-2018-09-872549 · 2019 · External reference
Prognostic Impacts of RHOA G17V Mutation in Cell‐Free DNA Assessed by Droplet Digital Polymerase Chain Reaction in Patients With Angioimmunoblastic T‐Cell Lymphoma
10.1111/bjh.20071 · 2025 · External reference
Integrative Clinicopathological and Molecular Analyses of Angioimmunoblastic T‐Cell Lymphoma and Other Nodal Lymphomas of Follicular Helper T‐Cell Origin
10.3324/haematol.2016.158428 · 2017 · External reference
Somatic RHOA Mutation in Angioimmunoblastic T Cell Lymphoma
10.1038/ng.2872 · 2014 · External reference
RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis
10.1016/j.ccell.2018.01.001 · 2018 · External reference
Nucleoporin‐93 Reveals a Common Feature of Aggressive Breast Cancers: Robust Nucleocytoplasmic Transport of Transcription Factors
10.1016/j.celrep.2022.110418 · 2022 · External reference
Cleavage of CAD by Caspase‐3 Determines the Cancer Cell Fate During Chemotherapy
10.1038/s41467-025-60144-2 · 2025 · External reference
Gene Expression Signatures Delineate Biological and Prognostic Subgroups in Peripheral T‐Cell Lymphoma
10.1182/blood-2013-11-536359 · 2014 · External reference
Chasing the Ghost Proteome in the Dark Matter
10.1016/j.mcpro.2025.101076 · 2025 · External reference
Hallmarks of Cancer: The Next Generation
10.1016/j.cell.2011.02.013 · 2011 · External reference
Clinicopathologic Characteristics of Angioimmunoblastic T‐Cell Lymphoma: Analysis of the International Peripheral T‐Cell Lymphoma Project
10.1200/jco.2011.37.3647 · 2013 · External reference
Brentuximab Vedotin With Chemotherapy for CD30‐Positive Peripheral T‐Cell Lymphoma (ECHELON‐2): A Global, Double‐Blind, Randomised, Phase 3 Trial
10.1016/s0140-6736(18)32984-2 · 2019 · External reference
